Guide to Transfers of Product Authorisations and Parallel Product Authorisations for Human Medicines
17 November 2011
A marketing authorisation or parallel import licence may be transferred from the existing authorisation/licence holder to another holder using a transfer procedure.
A transfer may occur before a product is authorised or after authorisation, to a company related to the existing holder or to an unrelated company.
The transfer procedure must be used where the legal entity of an authorisation/licence holder is changed as (P)PA [(Parallel)Product Authorisation] product authorisations are transferred to a new company number.
For further information, click on the guide below:
Guide to Transfers of Product Authorisations and Parallel Product Authorisations for Human Medicines
To see the most recent changes to this guide, click on the link below:
Guide to Transfers of Product Authorisations and Parallel Product Authorisations for Human Medicines_changes tracked